Background: Lung cancers are occasionally detected on coronary artery calcium (CAC)-scoring computed tomography (CT). However, the cause of delayed diagnosis and prognostic factors have not been studied. Purpose: To investigate the causes of delayed diagnosis of lung cancer in patients who undergo CAC-scoring CT and to identify predictors of mortality. Material and Methods: A total of 151 patients who were diagnosed with lung cancer and had undergone CACscoring CT from January 2010 to December 2014 were retrospectively enrolled. The reasons for delayed diagnosis were reviewed. Follow-up data on all-cause mortality were obtained. Cox proportional hazards regression analysis was used to identify predictors of mortality. Analyses of solid and subsolid subgroups were performed. Results: Among the 151 patients, 86 lesions (56.9%) were solid and 63 (41.7%) were subsolid. The main causes of delayed diagnosis were detection (48%) and interpretation (22%) errors. Age, size, unresectable stage at the time of diagnosis, and stage shift were independent prognostic factors throughout the entire and in the solid subgroup (all P < 0.2). There were no significant prognostic factors in the subsolid subgroup. Conclusion: In conclusion, avoidance of detection and interpretation errors may prevent delayed diagnosis of lung cancer on CAC-scoring CT. Older age, larger tumor size, unresectable stage at the time of diagnosis, and stage shift were associated with poor survival in patients with solid lung cancers but not in those with subsolid lung cancers.
Introduction
The incidence of lung cancer is increasing worldwide, and early diagnosis of the disease is important (1) . The recent National Lung Screening Trial (NLST) showed that annual low-dose computed tomography (CT) screening for lung cancer reduces cancer-related mortality in high-risk patients (2) . Importantly, the leading cause of death in the NLST study population was cardiovascular disease rather than lung cancer (2) . Conversely, 20% of the primary prevention cohort for atherosclerotic cardiovascular disease (aged 55-77 years) was considered eligible for lung cancer screening (3) . In view of the results of previous studies and the overlap between the risk factors for coronary artery disease (CAD) and lung cancer, there could be a high probability of CAD in patients undergoing CT screening for lung cancer and vice versa (3, 4) .
Coronary artery calcium (CAC)-scoring CT is generally accepted as the standard of reference for determination of the risk of cardiac events (5) . At many institutions, CAC-scoring CT is often performed before cardiac CT, and some centers use a wide field of view (FOV) that can evaluate the entire thorax and lung parenchyma. Therefore, some researchers proposed to use single full thorax scan for screening lung cancer and CAC in patients who met both CAC and lung cancer screening criteria (6) .
However, little is known about the prevalence and characteristics of lung cancer detected on CAC-scoring CT. Previous studies of pulmonary nodules detected on cardiac CT angiography have focused mainly on prevalence, detection rates using limited and wide FOVs, and cost-effectiveness (7) (8) (9) (10) . Despite the need for timely diagnosis of lung cancer, no studies have explored the factors that contribute to delayed diagnosis of lung cancer in patients who undergo CACscoring CT or their prognosis.
The aim of this study was to investigate the factors that contribute to delayed diagnosis of lung cancer in patients undergoing CAC scoring CT and to determine the prognostic factors that predict mortality.
Material and Methods

Patients
Approval for this retrospective cohort study was obtained from the institutional review board at Severance Hospital, Yonsei University College of Medicine. The need for informed consent was waived.
We searched our database for cardiac CT between January 2010 and December 2014 and included 333 examinations in 324 patients who met the following criteria: (i) adult patients (age !20 years) who underwent CAC-scoring CT examinations during the study period; and (ii) who had a diagnosis of "lung cancer" in their electronic medical records (Fig. 1) . We excluded 120 patients who did not have a demonstrable lesion as they had already undergone lung cancer surgery, 27 patients who were known to have lung cancer before CAC-scoring CT, 22 patients in whom there was no histopathologic confirmation of lung cancer, and four patients with benign lesions. 
CT scanning
The CT scans were performed using a secondgeneration dual-source scanner (Somatom Definition Flash; Siemens Medical Solutions, Erlangen, Germany) or a 64-channel multi-detector scanner (Sensation 64; Siemens Medical Solutions) in the craniocaudal direction during a single breath-hold. Nonenhanced prospective electrocardiogram (ECG)-gated sequential scanning with a tube voltage of 120 kV and a tube current of 50 mAs was performed to measure CAC. The CAC-scoring CT scan range was from the upper margin of the apex of the lung to the base of the heart. The scan was performed at 70% or 35% of the R-R interval, depending on the patient's heart rate. The images were reconstructed with a slice thickness of 3 mm and an increment of 3 mm with a medium sharp kernel (B35f). The images were reconstructed using a FOV including the entire thorax (Fig. 2) . Cardiac CT angiography was performed after CAC scoring CT depending on the indication for the examination.
Evaluation of clinical and CT characteristics
The medical and radiologic records of 151 patients were reviewed. The following demographic and clinicopathologic data were recorded: (i) age and sex; (ii) smoking history (assessed at the time of CAC-scoring CT); (iii) indication for CAC scoring CT; (iv) risk factors for CAD, including hypertension, history of stroke, dyslipidemia, and diabetes mellitus; (v) histologic diagnosis; and (vi) lung cancer stage. To stage primary lung cancer, we used the international staging system adopted by American Joint Committee on Cancer (AJCC) 7th edition (11) . The resectability of lung cancer was also assessed (resectable stage IIIA, unresectable !stage IIIB) (12) . In 91 patients (60.2%), pathological stage was available at the time of final diagnosis. Otherwise, final stage was clinically determined by CT, positron emission tomography (PET)-CT, brain magnetic resonance imaging, and bone scan reports.
All CAC-scoring CT images were independently reviewed by two cardiothoracic radiologists with six and 10 years of experience. Decisions regarding CT findings were made by consensus. The following CT findings were recorded for each lesion: (i) size (greatest tumor diameter which was measured in axial view); (ii) location; and (iii) characteristic (subsolid nodule [SSN] or solid nodule). SSNs were classified as pure groundglass nodules (GGN) and part-solid nodules (13) .
Reasons for delayed diagnosis and evaluation of follow-up data
Clinical follow-up data were obtained from electronic medical records. Since the cause of death was uncertain in the majority of mortality cases of our study population, we set the primary endpoint as all-cause mortality. "Time to diagnosis" was defined as the period of time from CAC-scoring CT to the time of final pathologic diagnosis (by biopsy or surgery). "Stage shift" was defined as a change between a patient's stage on initial CAC-scoring CT and stage at the time of diagnosis. "Delayed diagnosis" was deemed to have occurred when final diagnosis was made later than cut-off value for time to diagnosis. The cut-off value for time to diagnosis was set by receiver operating characteristic (ROC) curve analysis for identification of stage shift.
We classified the reasons for delayed diagnosis as follows (14): (i) the radiologist missed the lesion on initial CAC-scoring CT ("detection error"); (ii) the radiologist found a lesion but incorrectly interpreted it as non-malignant, e.g. inflammation ("interpretation error"): (iii) the clinician did not take action even though the radiologist detected and correctly interpreted the lesion as malignant ("no appropriate action"); (iv) a small SSN found on CAC-scoring CT showed interval growth during follow-up and was eventually confirmed as malignancy ("follow-up strategy for SSN"); and (v) "miscellaneous," e.g. a falsenegative biopsy or aspiration result. The reasons for delayed diagnosis were investigated in the entire study population as well as in the subgroups. Given that subsolid lung cancers are known to have a different disease course, we performed a subgroup analysis of the solid nodule and SSN groups (15, 16) . The CT imaging findings of lung cancers that contained detection or interpretation errors were reviewed (14) . 
Statistical analysis
Categorical baseline characteristics are expressed as the number and percentage and the continuous variables are expressed as the mean and standard deviation or as the median and IQR. Differences between categorical variables were analyzed using the chisquare test or Fisher's exact test and differences between continuous variables were analyzed using the Student's t-test for independent samples or the Mann-Whitney U test. Intraclass correlation coefficient (ICC) was calculated to investigate the interobserver agreement of measuring tumor size. Logistic regression analyses were used to identify associations between stage shift and clinical and CT variables. Cox proportion hazards regression analyses were used to identify associations between the clinical and CT variables and outcomes, as well as potential predictors of mortality. Variables with a P value < 0.1 in univariate logistic and Cox regression analyses were included in the multivariate analysis. In the multivariate Cox regression analyses, P values < 0.2 were considered to be statistically significant; otherwise, P values < 0.05 were considered statistically significant.
Results
Patient and lesion characteristics
The clinical characteristics and CT findings are summarized in Table 1 . The most common indication for CT was chest pain or dyspnea (47.0%). The most common location of lung cancer was the right upper lobe (29.8%). The median size of lung cancer based on CAC-scoring CT was 19.9 mm (IQR ¼ 13.4-30.2 mm) and there was an excellent inter-observer agreement in size measurement (ICC ¼ 0.995, 95% confidence interval [CI] ¼ 0.993-0.996). The majority of the lesions were solid (56.9%), followed by part-solid lesions (29.1%) and pure GGNs (12.6%).
Histopathologic findings and lung cancer staging
The most common pathology was adenocarcinoma (72.2%), followed by squamous cell carcinoma (15.9%) ( Table 2 ). Five patients (3.3%) were diagnosed with non-small cell lung cancer with no specific cell type. The tentative lung cancer stages at the time of CAC-scoring CT were stage I in 70.9% of patients, followed by stage IV in 9.9%. The final lung cancer stage at the time of diagnosis was usually stage I (57.6%), followed by stage IV (19.2%). A stage shift was identified in 22 patients (15.2%). Six patients could not be evaluated using the AJCC system at the time of CAC-scoring CT and at the time of final diagnoses (three metastases, two recurrences of previous lung cancer, one primary lung cancer with tentative clinical stage II or III).
Among 29 patients with stage IV disease at final diagnosis, nine patients had M1a disease (contralateral lung or pleural metastasis) and 20 patients had M1b disease (metastasis to brain in six patients, bone metastasis in four, abdominal solid organ metastasis in two, and multiple extra-thoracic organ metastasis in eight). Data are presented as n (%) unless otherwise specified. *The data are presented as the median (IQR). † Four lesions were unavailable for size measurement (two infiltrative lesions and two hematolymphangitic carcinomatoses). CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CT, computed tomography; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; GGN, ground-glass nodule; LN, lymph node.
Reasons for delayed diagnosis and imaging findings on CAC-scoring CT There were differences in the cut-off values for delayed diagnosis between the entire study population and subgroups (Table 3) . Fifty patients (33.1%) were compatible with delayed diagnosis in the entire study population. Detection error was the most common cause of delayed diagnosis (48%) in the entire study population and in the solid lung cancer subgroup, followed by interpretation error (Figs. 2 and 3) . However, follow-up strategy for a SSN was the second most common cause of delayed diagnosis in the SSN subgroup. Lung parenchymal lesion (probable human error) was the most common CT findings in patients with a delayed diagnosis of lung cancer attributable to detection error (54.2%). The next most common CT finding was pleural attached nodule (16.7%). In terms of interpretation error, lung cancer was most commonly misinterpreted as pneumonia or an inflammatory lesion (36.4%). The mean lesion size on initial CAC-scoring CT was significantly smaller in cases of delayed diagnosis of lung cancer attributable to detection error than those attributable to other causes (median ¼ 9.8 mm vs.
16.7 mm, P < 0.001, Supplementary 
Characteristics of patients with and without stage shift
In the entire study population, patients with a stage shift were significantly older than those without a stage shift (Supplementary Table 2 ; P ¼ 0.035). The lesion size on CAC-scoring CT was significantly smaller in patients with a stage shift than in those without a stage shift in the solid subgroup (P ¼ 0.030). The time to diagnosis was significantly longer in the group with a stage shift than in the group without a stage shift in the entire study population and in the solid subgroup (P < 0.001). Other clinical variables and CT characteristics were not significantly different between the groups with and without a stage shift.
Predictors of stage shift
In univariate logistic regression analysis, smaller tumor size, longer time to diagnosis, a resectable stage at the time of CAC-scoring CT, and non-adenocarcinoma pathology were significant predictors of a stage shift in the entire study population (all P < 0.1, Supplementary Table 3 ). In the solid subgroup, smaller tumor size, longer time to diagnosis, and resectable stage at the time of CT were significant predictors in univariate analysis (all P < 0.1, not shown). No significant predictor was identified in the SSN group (all P > 0.1, not shown).
In multivariate analysis with adjustment for other variables, longer time to diagnosis (P ¼ 0.003) and non-adenocarcinoma pathology (P ¼ 0.003) were significant predictors of a stage shift in the entire study population. In the solid subgroup, longer time to diagnosis was a significant independent predictor of a stage shift (odds ratio ¼ 1.063, 95% CI ¼ 1.017-1.112, P ¼ 0.007). Multivariate analysis was not performed for the SSN subgroup because no significant factors had been identified in the univariate analysis.
Predictors of mortality
Of the 151 patients, 43 patients died, 101 patients survived, and seven patients were lost during the follow-up period. The median survival time in all study population (151 patients) was 41 months (IQR ¼ 23.1-70.7 months). The median survival time of 43 patients who died was 13.8 months (IQR ¼ 9.5-26.5 months) and the median follow-up period of patients who Data are presented as n (%) of patients. *Ultrasound-guided biopsy (n ¼ 9), fluoroscopy-guided biopsy (n ¼ 2), sputum cytology (n ¼ 1), liver biopsy (n ¼ 1). † Six cases were unavailable. CAC, coronary artery calcium; CT, computed tomography; NSCLC, nonsmall cell lung cancer; TBLB, transbronchial lung biopsy.
were alive was 65.9 months (IQR ¼ 49.7-78.3 months).
In a univariate Cox proportional hazards model, older age, heavy smoking, larger tumor size, unresectable stage at the time of final diagnosis, and stage shift were associated with increased mortality in the entire study population and in the solid subgroup (all P < 0.1; Table 4 ). In the SSN subgroup, unresectable stage at the time of diagnosis and a stage shift were associated with increased mortality (both P < 0.1). According to multivariate Cox regression analysis with adjustment for clinical and imaging variables, older patient age, larger tumor size, an unresectable stage at the time of diagnosis, and a stage shift were associated with increased hazard ratios for mortality in the entire study population and in the solid subgroup (all P < 0.2). However, no significant prognostic factor was identified in the SSN subgroup.
Discussion
In our study, the most common reasons for delayed diagnosis of lung cancer on CAC-scoring CT were detection and interpretation errors. Older age, larger tumor size, an unresectable stage at the time of diagnosis, and stage shift were independently associated with poor survival in the entire study population and in the solid subgroup. However, no significant prognostic factors were identified in the SSN subgroup.
Concern has been raised regarding pulmonary nodules detected on cardiac or CAC-scoring CT that are subsequently confirmed to be malignant lesions. Despite the relatively low prevalence of malignant lesions, the use of the follow-up strategy for detected pulmonary nodules and optimal CT scan FOVs are important issues because a missed lung cancer or a delay in diagnosis significantly impacts the prognosis. There are a few reports on lung cancer detected on cardiac or CAC-scoring CT, most of them focused on the incidence of lung cancer based on lung nodules that were detected incidentally (8, 10) . However, the previous studies have not reported on prognostic factors or the causes for delayed diagnosis.
In our study, the most common reason for a delayed diagnosis was detection error. Correspondingly, there were a few studies attempted to determine the causes of delayed diagnosis of lung cancer in the lung cancer screening trials with low-dose chest CT in high-risk patients (14, 17, 18) . The rates of detection error in total lung cancer in previous studies 8.1% in the NELSON trial and 3.4% in NLST, which were much lower than the rate in our study (23.8%) (14, 18) . There is also a difference in the main CT findings for missed Data are presented as n (%) of patients unless otherwise specified. *Other includes one lymphocytic interstitial pneumonia, one case that described only imaging findings (consolidation) without any interpretation. CAC, coronary artery calcium; CT, computed tomography.
lesions between the NELSON trial (endobronchial localization, an adjoining bullous structure, and lymphadenopathy) (14) and our study (human error). The frequency of detection error in our study was higher than that reported in a chest CT screening study. The reason for this finding may be the small lesion size (average ¼ 10.6 mm), in which 50% (12/24) of missed lung cancers were < 10 mm. This tendency for small lung cancers to be missed was also reported in the low-dose chest CT lung cancer screening trial (14, 18) and other studies regarding missed lung cancers on chest CT (18) (19) (20) . The interpretation error rate was also much lower in lung cancer screening trials than in our study (NELSON trial 0.8%, NLST 2.8%, vs. our study 6.6%). We believe that the differences in frequency of detection and interpretation errors between the studies reflect differences in purpose and intent with regard to detection of lung cancer lesions between CAC-scoring CT and chest CT performed for lung cancer screening. A follow-up strategy for a SSN was the second most common cause of diagnostic delay in patients with subsolid lung cancers. This finding reflects the present guidelines for management of SSNs, in which the recommendations vary according to the size of the nodule and the internal solid component (21) . For this reason, we consider that follow-up strategy for SSNs were not a meaningful cause of diagnostic delay.
We found that older age, a larger tumor size, an unresectable stage at the time of diagnosis, and stage shift were independently associated with a poor prognosis in the entire study population and in the solid subgroup. Tumor size is well known to be the factor determining the T stage of lung cancer and is also known to be a stage-independent prognostic factor (11, (22) (23) (24) . Age is also a well-known stage-independent prognostic factor affecting survival in patients with lung cancer (25, 26) . Our present findings identify stage shift as a further stage-independent prognostic factor, which was associated with a longer time to diagnosis in both the entire study population and the solid subgroup.
No significant prognostic factors were identified in the SSN subgroup. A longer time to diagnosis was not associated with a stage shift in this subgroup, which is consistent with the indolent nature of subsolid lung cancer. This finding reflects the differences in disease course and prognosis of subsolid and solid lung cancers. Subsolid lung cancers are known to have a longer doubling time than solid lung cancers (16, 27) . Similarly, most of the subsolid lung cancers in our study were stage I at the time of CT and at the time of diagnosis.
Our study has several limitations. First, it was retrospective and included a relatively small number of patients from a single center. Second, our study evaluated the outcome based on full thoracic FOV CACscoring CT and our results may not be generalizable to limited FOV scan. Moreover, we did not consider the potential harm of additional radiation exposure caused by full thoracic FOV. Third, we did not measure the solid components of SSNs, despite several studies demonstrating that the prognosis depends on the size of the solid component in SSNs (28) (29) (30) . However, we believe that CAC-scoring CT is not suitable for measuring solid components in lung cancers, due to difference of slice thickness and reconstruction filters from non-ECG-gated chest CT (31) . Fourth, the prevalence of lung cancer on CAC scoring CT in our study was slightly higher (0.66%, 151/22,792) than that reported in a previous meta-analysis of cardiac CT studies (0.5%) (10) . We suggest that this difference may be explained by the different patient characteristics between the studies; for example, the mean age of patients in our study was older than that in the other studies (median ¼ 69.4 years vs. 53-66 years). Fifth, in a substantial portion of the study (66/151, 43.7%), stage at CAC-scoring CT was assessed by CT imaging alone, and two-thirds of them had delayed diagnosis of lung cancer. Despite considering the discordance between and pathological and clinical staging in small-sized primary lung cancer, insufficient staging information may affect the delayed diagnosis (32) .
In conclusion, detection error and interpretation error are the most common reasons for delayed diagnosis of lung cancers on CAC-scoring CT. Older age, larger tumor size, and stage shift were stageindependent predictors of increased mortality in solid lung cancers. Increased awareness of the causes of delayed diagnosis is required when interpreting CACscoring CT, to avoid delayed diagnosis and a stage shift in patients with lung cancer.
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